Real-World Characteristics of Patients with Wild-Type Transthyretin Amyloid Cardiomyopathy: An Analysis of Electronic Healthcare Records in the United States

ConclusionsThe clinical characteristics of patients with ATTRwt-CM who were prescribed tafamidis in the real world were broadly comparable with those who took part in ATTR-ACT. Further studies are needed to evaluate hereditary and ATTRwt-CM patient populations in the real world and assess the long-term outcomes associated with disease management pathways.Clinical Trials RegistrationClinicalTrials.gov identifier: NCT01994889.
Source: American Journal of Cardiovascular Drugs - Category: Cardiology Source Type: research